Eli Lilly (LLY) stock falls as rival Novo Nordisk (NVO) plans to cut Wegovy, Ozempic & Rybelsus U.S. list prices from Jan 1, ...

The drugmaker is introducing a new, more convenient way to inject its blockbuster obesity drug, Zepbound.

Eli Lilly hopes the device can be more convenient for Zepbound users and lead to more people taking the drug.

Novo Nordisk A/S NVO announced plans on Tuesday to cut the list prices of its GLP-1 drugs by up to 50% in the U.S. starting in 2027. The price reduction will affect the obesity injection Wegovy, its ...

Feb 23 (Reuters) - Eli Lilly said on Monday it received the U.S. Food and Drug Administration's approval to launch a four-dose KwikPen for its weight-loss drug Zepbound, delivering a full month of the ...

Swole — without the serious side effects. For generations, gym rats have turned to illicit steroid use for bigger muscles, despite the numerous side effects and dangerous risks, from roid rage and ...

Got a confidential news tip? We want to hear from you. Sign up for free newsletters and get more CNBC delivered to your inbox Get this delivered to your inbox, and ...

Consolidation of four doses may lower secondary packaging complexity and improve fill-finish throughput predictability, although Lilly has not quantified manufacturing efficiency gains. Multi-dose use ...

Related Videos: LLY.MX AI is disrupting drug discovery faster than expected Opening Bid Unfiltered is available on Apple Podcasts, Spotify, YouTube, or wherever you get your podcasts. If you aren’t ...